Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The CCDC15 divergent transcript (CCDC15-DT) is a long non-coding RNA gene located antisense to the CCDC15 coding gene, arising from bidirectional (divergent) transcription at the CCDC15 promoter region. Its precise function is not fully established, but divergent transcripts like CCDC15-DT are commonly linked to the fine-tuning of gene expression, especially involving transcriptional regulation and development-related genes. While CCDC15 itself encodes a centriole inner scaffold protein critical for centriole and cilium structure, CCDC15-DT does not encode a protein and is not considered a receptor, enzyme, or therapeutic target in drug development contexts. There are no known clinical drugs, disease roles, or safety concerns directly associated with CCDC15-DT at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CCDC15 divergent transcript (CCDC15-DT).